Article

Predictors of violent behavior among acute psychiatric patients: Clinical study

Psychiatry and Clinical Neurosciences (Impact Factor: 1.62). 05/2008; 62(3):247 - 255. DOI: 10.1111/j.1440-1819.2008.01790.x

ABSTRACT Aim:  Violence risk prediction is a priority issue for clinicians working with mentally disordered offenders. The aim of the present study was to determine violence risk factors in acute psychiatric inpatients.Methods:  The study was conducted in a locked, short-term psychiatric inpatient unit and involved 374 patients consecutively admitted in a 1-year period. Sociodemographic and clinical data were obtained through a review of the medical records and patient interviews. Psychiatric symptoms at admission were assessed using the Brief Psychiatric Rating Scale (BPRS). Psychiatric diagnosis was formulated using the Structured Clinical Interview for DSM-IV. Past aggressive behavior was evaluated by interviewing patients, caregivers or other collateral informants. Aggressive behaviors in the ward were assessed using the Overt Aggression Scale. Patients who perpetrated verbal and against-object aggression or physical aggression in the month before admission were compared to non-aggressive patients, moreover, aggressive behavior during hospitalization and persistence of physical violence after admission were evaluated.Results:  Violent behavior in the month before admission was associated with male sex, substance abuse and positive symptoms. The most significant risk factor for physical violence was a past history of physically aggressive behavior. The persistent physical assaultiveness before and during hospitalization was related to higher BPRS total scores and to more severe thought disturbances. Higher levels of hostility–suspiciousness BPRS scores predicted a change for the worse in violent behavior, from verbal to physical.Conclusion:  A comprehensive evaluation of the history of past aggressive behavior and psychopathological variables has important implications for the prediction of violence in psychiatric settings.

Full-text

Available from: Marco Menchetti, Oct 26, 2014
0 Followers
 · 
73 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Paper Felice Loi, Karl Marlowe, Dominic McLernon-Johnson Millharbour PICU, Tower Hamlets Centre for Mental Health, Mile End Hospital, London, UK Perspective: PracticeKeywords: Broset Violence Checklist; seclusion; violence; psychiatry Abstract Background. Violence is common on acute psychiatric wards. Although seclusion is usually employed as last resort treatment to contain high risky behaviors, its implementation is clouded with uncertainty due to the lack of pragmatic psychometric tools. The Broset Violence Checklist (BVC) is a reliable and validated instrument to predict imminent violence, it is not used to assess the appropriateness of the use of seclusion. Methods. Developed an 8-item modified version of the BVC, the East London Modified-Broset (ELM-Broset). It was retrospectively analyzed for its sensitivity and specificity with regards to secluding high-risky psychiatric inpatients (n = 43; incident n = 313), and to compare it to the BVC for the same inpatient group. Data analyses were carried out using logistic regression and ROC Curves. Results. The ELM-Broset showed good accuracy in predicting the use of seclusion with a sensitivity: 88.2%; specificity: 76.3%; AUC = 0.88; p <0.000; 95% C.I. [0.83, 0.94]; as compared to the predictive value of the standard BVC: sensitivity 82%; specificity: 55%; AUC = 0.74; p = 0.000; 95% C.I. [0.66; 0.82]. Pairwise comparison of the ROC curves showed a statistically significant difference: Δ = 0.148; SE: 0.022; p < 0.0001; 95% C.I. [0.10, 0.19]; with large effect size: Z = 6.63. Conclusions. The ELM-Broset is a sensitive and specific psychometric instrument which can be used to guide the decision-making process when implementing seclusion for high risk psychiatric inpatients.
    Fourth International Conference on Violence in the Health Sector Towards safety, security and wellbeing for all, pp 304 - 309; 10/2014
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective To evaluate the efficacy of lurasidone for schizophrenia using an established five-factor model of the Positive and Negative Syndrome Scale (PANSS). Methods Patient-level data were pooled from five randomized, double-blind, placebo-controlled, 6-week studies of lurasidone (fixed doses, 40–160 mg/d) for patients with an acute exacerbation of schizophrenia. Changes in five established PANSS factors were assessed using mixed-model repeated measures analysis. Results Compared with placebo (n = 496), lurasidone (n = 1029, dose groups pooled) significantly improved the PANSS total score at Week 6 (−22.6 vs. −12.8; P < 0.001; effect size, 0.45), as well as all factor scores (P < 0.001 for each): positive symptoms (−8.4 vs. −6.0; effect size, 0.43), negative symptoms (−5.2 vs. −3.3; effect size, 0.33), disorganized thought (−4.9 vs. −2.8; effect size, 0.42), hostility/excitement (−2.7 vs. −1.6; effect size, 0.31), and depression/anxiety (−3.2 vs. −2.3; effect size, 0.31). Separation from placebo occurred at Week 1 for the positive symptoms, disorganized thought, and hostility/excitement factors and at Week 2 for the other factors. Conclusions In this pooled analysis of short-term studies in patients with acute schizophrenia, lurasidone demonstrated significant improvement for each of the five PANSS factor scores, indicating effectiveness across the spectrum of schizophrenia symptoms.
    European Psychiatry 09/2014; 30(1). DOI:10.1016/j.eurpsy.2014.08.001 · 3.21 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Aggressive patients are not uncommon in acute inpatient behavioral health units of general hospitals. Prior research identifies various predictors associated with aggressive inpatient behavior. This prospective observational study examines the demographic and clinical characteristics of aggressive inpatients and the routine medications these patients were receiving at discharge.
    06/2014; 16(3). DOI:10.4088/PCC.13m01589